Clariant AG (FRA:CLRN)
9.33
-0.19 (-1.94%)
At close: Jul 30, 2025
Intra-Cellular Therapies Market Cap
Clariant AG has a market cap or net worth of €2.97 billion as of August 1, 2025. Its market cap has decreased by -38.58% in one year.
Market Cap
2.97B
Enterprise Value
4.87B
Revenue
4.35B
Ranking
n/a
PE Ratio
24.53
Stock Price
$9.33
Market Cap Chart
Since August 4, 1995, Clariant AG's market cap has increased from 1.01B to 2.97B, an increase of 192.42%. That is a compound annual growth rate of 3.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 2.97B | -15.83% |
Dec 30, 2024 | 3.53B | -19.69% |
Dec 29, 2023 | 4.39B | -10.02% |
Dec 30, 2022 | 4.88B | -19.35% |
Dec 30, 2021 | 6.05B | 5.97% |
Dec 30, 2020 | 5.71B | -12.94% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 294.64B |
Siemens Aktiengesellschaft | 176.59B |
Deutsche Telekom AG | 154.90B |
Allianz SE | 131.98B |
Siemens Energy AG | 80.60B |
Rheinmetall AG | 79.38B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 74.19B |
Deutsche Bank Aktiengesellschaft | 55.92B |